CorMedix Inc.
CorMedix Inc. (CRMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRMD · as of Jun 8, 2026
Key Statistics
Explore CorMedix Inc. Data
crmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 100.0%
The CRMD analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $14.00, representing +66.96% upside from the current price of $8.38.
Competitors & Peers
crmd competitorsCRMD
ABUS
BCAX
EYPT
KURA
NBTXStock Performance
Full HistoryAbout CorMedix Inc.
CorMedix Inc. a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States…
what is cormedix inc. · crmd stock overview · cormedix inc. company profile · who is cormedix inc. ceo · crmd NASDAQ · cormedix inc. headquarters · cormedix inc. business segments
About Stock Overview & Key Data
CorMedix Inc. (CRMD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 13, 2010. As of the latest trading session, CRMD stock price is $8.38, with a market capitalization of $657.8M. The stock has returned -41.18% over the past 12 months and -27.43% year-to-date.
According to 8 Wall Street analysts, the consensus rating for CorMedix Inc. stock is Buy, with an average 12-month price target of $14.00. In fiscal year 2025, CorMedix Inc. reported revenue of $311.7M and net income of $163.1M. For detailed data — including CorMedix Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CorMedix Inc. (CRMD) stock price is $8.38. The stock is traded on NASDAQ under the ticker symbol CRMD. The 52-week range is $6.13 – $17.43.